1. Home
  2. Browse
  3. We need another 3R rule: repeat, r…
Article

We need another 3R rule: repeat, repeat, repeat!

Author(s) / Creator(s)

Hulten, Annika
Rannanpää, Saara

Other kind(s) of contributor

Janssen-Cilag Oy

Abstract / Description

There is consensus within the scientific community that replication studies are scientifically sound and bring added value and reliability to any discovery. It is also widely acknowledged that replications are not as common as they perhaps should be. The reasons for this vary depending on the stakeholder - here we will discuss the matter from the perspective of the pharmaceutical industry. However, the views expressed here are our own and do not represent the official standpoint of our employer or the industry in general. We will focus this commentary on the issues related to replications of the clinical part of the drug development, as our expertise is most closely related to this area, but the matter is equally relevant and important in the pre-clinical domain.

Persistent Identifier

Date of first publication

2021-01-19

Journal title

Journal for Reproducibility in Neuroscience

Volume

2

Article number

1469

Publisher

University of Helsinki Libraries

Publication status

publishedVersion

Review status

notReviewed

Is version of

Citation

Hulten, A., & Rannanpää, S. (2021). We need another 3R rule: repeat, repeat, repeat!. Journal for Reproducibility in Neuroscience, 2, 1469. https://doi.org/10.31885/jrn.2.2021.1469
  • jrn.2.2021.1469.pdf
    Adobe PDF - 158.33KB
    MD5: f2a41930e317d2e15245d5f8cf281863
    Sharing Level 0 (Public Use) CC-BY-SA 4.0
     Download
    Description: Version of Record
    Rationale for choice of sharing level: Papers published in the Journal for Reproducibility in Neuroscience are CC BY-SA (https://journals.helsinki.fi/jrn/about)
  • Author(s) / Creator(s)
    Hulten, Annika
  • Author(s) / Creator(s)
    Rannanpää, Saara
  • Other kind(s) of contributor
    Janssen-Cilag Oy
  • PsychArchives acquisition timestamp
    2022-03-09T12:58:33Z
  • Made available on
    2022-03-09T12:58:33Z
  • Date of first publication
    2021-01-19
  • Abstract / Description
    There is consensus within the scientific community that replication studies are scientifically sound and bring added value and reliability to any discovery. It is also widely acknowledged that replications are not as common as they perhaps should be. The reasons for this vary depending on the stakeholder - here we will discuss the matter from the perspective of the pharmaceutical industry. However, the views expressed here are our own and do not represent the official standpoint of our employer or the industry in general. We will focus this commentary on the issues related to replications of the clinical part of the drug development, as our expertise is most closely related to this area, but the matter is equally relevant and important in the pre-clinical domain.
    en
  • Publication status
    publishedVersion
  • Review status
    notReviewed
  • Citation
    Hulten, A., & Rannanpää, S. (2021). We need another 3R rule: repeat, repeat, repeat!. Journal for Reproducibility in Neuroscience, 2, 1469. https://doi.org/10.31885/jrn.2.2021.1469
  • ISSN
    2670-3815
  • Persistent Identifier
    https://hdl.handle.net/20.500.12034/5003
  • Persistent Identifier
    https://doi.org/10.23668/psycharchives.5604
  • Language of content
    eng
  • Publisher
    University of Helsinki Libraries
  • Is version of
    https://doi.org/10.31885/jrn.2.2021.1469
  • Dewey Decimal Classification number(s)
    150
  • Title
    We need another 3R rule: repeat, repeat, repeat!
    en
  • DRO type
    article
  • Article number
    1469
  • Journal title
    Journal for Reproducibility in Neuroscience
    en
  • Volume
    2
  • Visible tag(s)
    JRepNeurosci